Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Century Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IPSC alerts

About Michael Diem

Michael Diem is recorded as CFO at Century Therapeutics, Inc. (IPSC) since April 11, 2023. Century Therapeutics, Inc. reported in an 8-K filed April 17, 2023 that Michael Diem was appointed Chief Financial Officer, effective April 11, 2023. Century Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Century Therapeutics, Inc. includes Brent Pfeiffenberger (CEO and Chairman), Gregory Russotti, Ph.D. (CEO), Brent Pfeiffenberger, Pharm.D. (Chairman) and 7 others.

“On April 11, 2023, the Board promoted Michael Diem to Chief Financial Officer.”
Century Therapeutics, Inc. Form 8-K, filed April 17, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Century Therapeutics, Inc.

Recent activity